How is the AMGEN Inc. today?

The AMGEN Inc. today is trading in the green, up by 1.49% at 282.56.

How has AMGEN Inc. performed historically?

The AMGEN Inc. is currently trading up 1.49% on an intraday basis in the past week the index rose 4.14%. The index has been down -7.61% in the past quarter and fell -5.87% in the past year. You can view this in the overview section.

What is AMGEN Inc. Annual Revenue?

AMGEN Inc. Annual Revenue rose 18.57%, in the last year to $33,424 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is AMGEN Inc. Annual Net Profit?

AMGEN Inc. Annual Net Profit fell 39.11% in the last year to $4,090 M. Its sector's average net profit growth for the last fiscal year was -11.1%.

What is AMGEN Inc. Price to Earning Ratio?

AMGEN Inc. Price to Earning Ratio is 25.61, higher than its sector PE ratio of 4.25.

What is AMGEN Inc. Stock Price?

AMGEN Inc. Stock Price fell 5.87% and underperformed its sector by 45.06% in the past year.

What is AMGEN Inc. Quarterly Revenue?

AMGEN Inc. Quarterly Revenue rose 9.43% YoY to $8,149 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is AMGEN Inc. Quarterly Net profit?

AMGEN Inc. Quarterly Net profit rose 1,630.97% YoY to $1,730 M. Its sector's average net profit growth YoY for the quarter was -212.96%.

What is AMGEN Inc. Debt to Equity Ratio?

AMGEN Inc. Debt to Equity Ratio of 10.23 is higher than 1. This implies that company assets are financed through debt.

What is AMGEN Inc. Return on Equity(ROE)?

AMGEN Inc. Return on Equity(ROE) for the last financial year was 67.55%, more than 20% in the last financial year, indicating an efficient use of shareholder's capital to generate profit.

What is AMGEN Inc. Mutual Fund Holding?

AMGEN Inc. Mutual Fund Holding increased by 3.81% in the last quarter to 66.06.

What is AMGEN Inc. Promoter Share Holding?

AMGEN Inc. Promoter Share Holding increased by 0.01% in the most recent quarter to 0.15%.

What is AMGEN Inc. Interest Coverage Ratio?

AMGEN Inc. Interest Coverage Ratio is 2.46, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

What is AMGEN Inc. Institutional Holding?

AMGEN Inc. Institutional Holding increased by 1.85% in the last quarter to 80.68.

AMGEN Inc. XNAS: AMGN

AMGEN Inc. Live Share Price Today, Share Analysis and Chart

Name: AMGEN Inc.: Is Infosys Ltd. worth buying?
Item: AMGEN Inc.
Rating: 2.080375
Author: Trendlyne DVM scores

Expensive Performer

about

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first ...

282.56 4.16 (1.49%)

1.8M XNAS Volume

XNAS 29 May, 2025 2:52 PM (EDT)

Board Meeting

The next board meeting for AMGEN Inc. is on 30 May 2025 for the purpose of Amgen Inc Annual General Meeting for 2025 See details

Medium Financial Strength

50.0 / 100

Expensive Valuation

27.0 / 100

Technically Neutral

39.4 / 100

Expensive Performer These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM

314

1Yr Price target upside is 11%

27 analysts

AMGEN Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

AMGEN Inc. Live Share Price Today, Share Analysis and Chart

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first ...

SWOT Analysis

AMGEN Inc. Live Price Chart

AMGEN Inc. FAQ

How is AMGEN Inc. today?

AMGEN Inc. today is trading in the green, and is up by 1.49% at 282.56.

How has AMGEN Inc. performed historically?

AMGEN Inc. is currently trading up 1.49% on an intraday basis. In the past week the stock rose 4.14%. stock has been down -7.61% in the past quarter and fell -5.87% in the past year. You can view this in the overview section.